Improved glucose tolerance after guanfacine treatment in hypertensive diabetic (type II) patients: one year follow up.
D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005951:Glucose Tolerance Test; D016316:Guanfacine; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D006146:Guanidines; D007328:Insulin; D010648:Phenylacetates; D014280:Triglycerides; D016316:Guanfacine; D002784:Cholesterol; D011188:Potassium